
Novavax Inc https://www.reuters.com/markets/companies/NVAX.O” target=”_blank” rel=”noopener”>(NVAX.O) said on Tuesday its updated protein-based COVID-19 vaccine generated an immune response against emerging forms of coronavirus such as the “Eris” subvariant in …
Read More